Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
194.9 USD | +0.42% | -0.41% | -24.89% |
12:00pm | Alzheimer's drug adoption in US slowed by doctors' skepticism | RE |
Apr. 19 | Needham Adjusts Price Target on Biogen to $294 From $300 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.89% | 28.22B | |
-2.68% | 85.68B | |
+5.53% | 41.4B | |
+54.75% | 24.64B | |
-4.97% | 16.98B | |
-34.20% | 13.29B | |
-17.96% | 11.66B | |
-12.10% | 11.65B | |
-0.45% | 8.18B | |
+4.51% | 7.78B |
- Stock Market
- Equities
- BIIB Stock
- News Biogen Inc.
- Biogen : UBS Adjusts Biogen PT to $442 From $475, Maintains Buy Rating